COVID-19 has drastically impacted the markets, investors, and the global economy at large. As the pandemic influences our society, Biotechnology has emerged as a vitally important industry, not just for our current crisis, but for the sustained well-being of people across the globe.
Join our investment team for a live webinar to learn more about our recently launched Biotechnology Portfolio and why we believe now is a great time to evaluate this asset class.
In the webinar we’ll discuss:
• Biotechnology’s history
• How we’re addressing newfound opportunity through targeted stock and direct indexing models
• Whether we see biotechnology as a trend for today, or long-term investment theme for providing growth and diversification opportunities to your clients’ portfolios